Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 59, Issue 1, Pages 663-665Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.04075-14
Keywords
-
Categories
Funding
- Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A120647]
Ask authors/readers for more resources
We investigated the effects of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis. Serum itraconazole concentrations were significantly lower in patients who received itraconazole with rifampin (median, 0.1 mu g/ml; P< 0.001) or rifabutin (median, 0.34 mu g/ml; P< 0.001) than those receiving itraconazole alone (median, 5.92 mu g/ml). Concomitant use of rifampin or rifabutin and itraconazole should be avoided in patients with chronic pulmonary aspergillosis and coexisting mycobacterial infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available